Appendectomy, LaparoscopicNCT01189916
Transrectal NOTES Appendectomy - Feasibility Study
A study testing Endoscopically assisted Appendectomy Surgery in people with Appendectomy, Laparoscopic and Endoscopy, run by Northwestern University at 1 site in United States.
Trial summary
Natural orifice translumenal endoscopic surgery (NOTES) has revolutionized the concept of minimally invasive surgery. NOTES is currently performed through transgastric or transvaginal approaches. The transvaginal approach is technically easier, but is only available to women. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Appendectomy, Laparoscopic, Endoscopy
- What is being tested?
- Endoscopically assisted Appendectomy Surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 4 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2010to Oct 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ability to undergo general anesthesia
- Age > 18 yrs
- ability to give informed consent
- requires total proctocolectomy,total abdominal colectomy, completion proctectomy, or sigmoidectomy
- absence of exclusion criteria
Who cannot join
- age < 18
- pregnancy
- emergency operation
- contraindication for laparoscopic surgery
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Transrectal - Natural Orifice Translumenal Endoscopic Surgery (NOTES)
Natural orifice translumenal endoscopic surgery (NOTES) has revolutionized the concept of minimally invasive surgery. NOTES is currently performed through transgastric or transvaginal approaches. The transvaginal approach is technically easier, but is only available to women. A transrectal approach has been proposed as a potential alternative to transvaginal NOTES for men. Fortunately, the technology to facilitate transrectal access and closure for NOTES has been in use for over twenty years, in the form of transanal endoscopic microsurgery (TEM) platforms.
We hypothesize that transrectal NOTES appendectomy is feasible in humans using a flexible endoscope and a TEM platform to assist with transrectal access and closure. After a pre-clinical study involving 5 cadavers, we will perform a clinical study of 10 transrectal NOTES appendectomies in patients already scheduled to undergo laparoscopic total proctocolectomy or total abdominal colectomy. The tissues involved in the NOTES procedure will be removed as part of the patient's originally scheduled operation, reducing the risk of morbidity as a result of an inadequate transrectal closure or appendiceal stump leak. We will measure operative times, complication rates, peritoneal contamination, and assess the integrity of the rectotomy closures. We hope to show that transrectal NOTES appendectomy is clinically feasible in humans using a TEM platform.
Read the detailed description
Pre-clinical phase: We conducted the first phase of the study in cadavers to troubleshoot the procedures, and to determine the optimal transrectal approach (anterior versus posterior). We have determined the anterior transrectal approach to be feasible and preferable to a posterior transrectal approach.
Clinical phase: The second phase of the project will be a feasibility study involving 10 human patients. We will recruit patients who are already scheduled to undergo elective laparoscopic total proctocolectomy, total abdominal colectomy, completion proctectomy , or sigmoidectomy from the surgical clinics.
Operative procedure: Patients will undergo a standard preoperative mechanical bowel prep, and will receive standard perioperative antibiotics and deep venous thrombosis (DVT) prophylaxis to reduce the risk of surgical site infection and thromboembolic complications, respectively. The subjects will be placed in lithotomy position, and undergo general anesthesia per usual routine. A laparoscopic team and a NOTES team will carry out the operation. The laparoscopic team will obtain laparoscopic access using standard laparoscopic technique. The NOTES team will perform rigid proctoscopy to assess the suitability of the rectum. The Karl-Storz (Tuttlingen, Germany) operating rectoscope will be used for TEM. After positioning the rectoscope, an intraluminal tissue oximetry measurement will be taken at the intended rectotomy site using an FDA-approved endoscopic tissue oximetry probe (T-Stat®, Spectros, Portola Valley, CA) passed through the TEM device. In human patients, we will collect peritoneal fluid for quantitative cultures at two time-points (immediately after peritoneal access, and after rectotomy closure), using a sterile suction trap attached in-line to a laparoscopic suction irrigator to determine the level of contamination from the procedure. The NOTES appendectomy will be completed using the flexible endoscope with laparoscopic assistance as needed. We will remove the specimen through the anus and close the rectal access site with a standard TEM closure. We will then perform a standard intraoperative insufflation test by submerging the pelvis and rectotomy site under saline, and insufflating the rectum to look for bubbles from the rectal closure site. At the conclusion of the NOTES procedures, we will remove the TEM device, and a laparoscopic team will proceed with laparoscopic proctocolectomy or total abdominal colectomy as originally planned. Once the specimen has been removed, we will use a bench-top test to determine the burst-pressure strength of the rectotomy closures. The specimen will be sent to pathology per standard routine, and postoperative care for the proctocolectomy or total abdominal colectomy patients will proceed per usual routine.
Outcome measurements: We will measure operative times, intraoperative complication rates, tissue oxygen saturation at the closure site, and rectotomy closure strength using an intraoperative insufflation test and an ex-vivo burst-pressure test. In the human cases we will also obtain intraoperative quantitative peritoneal fluid cultures to quantify the amount of peritoneal contamination as a result of the NOTES procedures.
Patients will be followed while in the hospital to assess for complications potentially related to the NOTES procedure. They will then return and be evaluated by their surgeon two weeks following their procedure. At this visit, any additional post-operative complications potentially related to the NOTES procedure will be noted in the patient's medical record.
Potential risks of this study include the usual risks involved in a standard laparoscopic proctocolectomy or total abdominal colectomy procedures including bleeding, infection, injury to surrounding structures, port/trocar site pain, anastomotic leak, incontinence, and sexual dysfunction. Additional potential risks include those related to flexible endoscopy, including bowel perforation and bleeding. In addition, there is the possibility that there may be new, unanticipated complications from this modified surgical technique. We estimate that the additional NOTES procedure will add 90 minutes to the general anesthesia time required for the patient's laparoscopic total proctocolectomy. Patient risks will be mitigated by having the procedure performed by surgeons with expertise in advanced laparoscopic, colorectal and NOTES surgery.
This feasibility study will evaluate the potential feasibility of this modified NOTES technique in 10 patients. Once a standardized technique is established and risks are shown to be low, a prospective comparative evaluation is planned to compare this modified approach to other NOTES approaches.
- Conditions
- Appendectomy, Laparoscopic, Endoscopy
- Being tested
- Endoscopically assisted Appendectomy Surgery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Endoscopically assisted Appendectomy SurgeryProcedure or surgery
Also called NOTES, Natural orifice translumenal endoscopic surgery, Transrectal Appendectomy
Using endoscopic instruments a small incision will be made in the rectum wall and the endoscope will be advanced into the insufflated peritoneal cavity. At least one laparoscopic trocars will be placed through the abdominal wall for laparoscopic instrument insertion to manipulate and cut tissue. The flexible endoscope will provide visualization of the surgical field and flexible endoscopic instruments may be used to augment surgical manipulation with the laparoscopic instruments. The appendix will be removed through the anus. Endoscopic clips, sutures or tissue anchors (TAS)will be used to close the rectal access site.
| Study group | Role | What they receive |
|---|---|---|
| Transrectal NOTES appendectomy | Experimental | These patients will undergo an experimental surgical procedure that uses flexible endoscopic instruments (i.e., inserted through the rectum). Receives: Procedure: Endoscopically assisted Appendectomy Surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
operative time
Measured: intraoperative
Secondary outcomes (2)
perioperative complications
Measured: two weeks
closure strength
Rectotomy closure strength will be measured intraoperatively using air insufflation, as well as postoperatively using pressurized fluid on the specimen.
Measured: intraoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Aug 2010 (estimated)
- Study startAug 2010
- Primary completionOct 2013
- Study completionOct 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Appendectomy, LaparoscopicStudies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 4 participants (actual)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Collaborators
- Natural Orifice Surgery Consortium for Assessment and Research
- Responsible party
- Principal investigator, Anne-Marie Boller, Northwestern University
- Investigators
- Anne-Marie Boller, M.D., Principal investigator, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01189916
- Sponsor's protocol ID
- STU00023311
- Status last verified
- Feb 2015
- First submitted
- 25 Aug 2010
- Last updated
- 13 Feb 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Transrectal - Natural Orifice Translumenal Endoscopic Surgery (NOTES)
- ClinicalTrials.gov ID
- NCT01189916
- Acronym / sponsor ID
- STU00023311
- Conditions
- Appendectomy, Laparoscopic, Endoscopy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 4 participants (actual)
- Lead sponsor
- Northwestern UniversityUniversity, hospital or other
- Collaborators
- Natural Orifice Surgery Consortium for Assessment and Research
- Study start
- Aug 2010
- Primary completion
- Oct 2013 (actual)
- Study completion
- Oct 2013 (actual)
- First posted
- 27 Aug 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Natural orifice translumenal endoscopic surgery (NOTES) has revolutionized the concept of minimally invasive surgery. NOTES is currently performed through transgastric or transvaginal approaches. The transvaginal approach is technically easier, but is only available to women. A transrectal approach has been proposed as a potential alternative to transvaginal NOTES for men. Fortunately, the technology to facilitate transrectal access and closure for NOTES has been in use for over twenty years, in the form of transanal endoscopic microsurgery (TEM) platforms.
We hypothesize that transrectal NOTES appendectomy is feasible in humans using a flexible endoscope and a TEM platform to assist with transrectal access and closure. After a pre-clinical study involving 5 cadavers, we will perform a clinical study of 10 transrectal NOTES appendectomies in patients already scheduled to undergo laparoscopic total proctocolectomy or total abdominal colectomy. The tissues involved in the NOTES procedure will be removed as part of the patient's originally scheduled operation, reducing the risk of morbidity as a result of an inadequate transrectal closure or appendiceal stump leak. We will measure operative times, complication rates, peritoneal contamination, and assess the integrity of the rectotomy closures. We hope to show that transrectal NOTES appendectomy is clinically feasible in humans using a TEM platform.
Detailed description
Pre-clinical phase: We conducted the first phase of the study in cadavers to troubleshoot the procedures, and to determine the optimal transrectal approach (anterior versus posterior). We have determined the anterior transrectal approach to be feasible and preferable to a posterior transrectal approach.
Clinical phase: The second phase of the project will be a feasibility study involving 10 human patients. We will recruit patients who are already scheduled to undergo elective laparoscopic total proctocolectomy, total abdominal colectomy, completion proctectomy , or sigmoidectomy from the surgical clinics.
Operative procedure: Patients will undergo a standard preoperative mechanical bowel prep, and will receive standard perioperative antibiotics and deep venous thrombosis (DVT) prophylaxis to reduce the risk of surgical site infection and thromboembolic complications, respectively. The subjects will be placed in lithotomy position, and undergo general anesthesia per usual routine. A laparoscopic team and a NOTES team will carry out the operation. The laparoscopic team will obtain laparoscopic access using standard laparoscopic technique. The NOTES team will perform rigid proctoscopy to assess the suitability of the rectum. The Karl-Storz (Tuttlingen, Germany) operating rectoscope will be used for TEM. After positioning the rectoscope, an intraluminal tissue oximetry measurement will be taken at the intended rectotomy site using an FDA-approved endoscopic tissue oximetry probe (T-Stat®, Spectros, Portola Valley, CA) passed through the TEM device. In human patients, we will collect peritoneal fluid for quantitative cultures at two time-points (immediately after peritoneal access, and after rectotomy closure), using a sterile suction trap attached in-line to a laparoscopic suction irrigator to determine the level of contamination from the procedure. The NOTES appendectomy will be completed using the flexible endoscope with laparoscopic assistance as needed. We will remove the specimen through the anus and close the rectal access site with a standard TEM closure. We will then perform a standard intraoperative insufflation test by submerging the pelvis and rectotomy site under saline, and insufflating the rectum to look for bubbles from the rectal closure site. At the conclusion of the NOTES procedures, we will remove the TEM device, and a laparoscopic team will proceed with laparoscopic proctocolectomy or total abdominal colectomy as originally planned. Once the specimen has been removed, we will use a bench-top test to determine the burst-pressure strength of the rectotomy closures. The specimen will be sent to pathology per standard routine, and postoperative care for the proctocolectomy or total abdominal colectomy patients will proceed per usual routine.
Outcome measurements: We will measure operative times, intraoperative complication rates, tissue oxygen saturation at the closure site, and rectotomy closure strength using an intraoperative insufflation test and an ex-vivo burst-pressure test. In the human cases we will also obtain intraoperative quantitative peritoneal fluid cultures to quantify the amount of peritoneal contamination as a result of the NOTES procedures.
Patients will be followed while in the hospital to assess for complications potentially related to the NOTES procedure. They will then return and be evaluated by their surgeon two weeks following their procedure. At this visit, any additional post-operative complications potentially related to the NOTES procedure will be noted in the patient's medical record.
Potential risks of this study include the usual risks involved in a standard laparoscopic proctocolectomy or total abdominal colectomy procedures including bleeding, infection, injury to surrounding structures, port/trocar site pain, anastomotic leak, incontinence, and sexual dysfunction. Additional potential risks include those related to flexible endoscopy, including bowel perforation and bleeding. In addition, there is the possibility that there may be new, unanticipated complications from this modified surgical technique. We estimate that the additional NOTES procedure will add 90 minutes to the general anesthesia time required for the patient's laparoscopic total proctocolectomy. Patient risks will be mitigated by having the procedure performed by surgeons with expertise in advanced laparoscopic, colorectal and NOTES surgery.
This feasibility study will evaluate the potential feasibility of this modified NOTES technique in 10 patients. Once a standardized technique is established and risks are shown to be low, a prospective comparative evaluation is planned to compare this modified approach to other NOTES approaches.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Transrectal NOTES appendectomy | Experimental | Procedure: Endoscopically assisted Appendectomy SurgeryThese patients will undergo an experimental surgical procedure that uses flexible endoscopic instruments (i.e., inserted through the rectum). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- ability to undergo general anesthesia
- Age > 18 yrs
- ability to give informed consent
- requires total proctocolectomy,total abdominal colectomy, completion proctectomy, or sigmoidectomy
- absence of exclusion criteria
Key exclusion criteria (4 listed)
- age < 18
- pregnancy
- emergency operation
- contraindication for laparoscopic surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Endoscopically assisted Appendectomy SurgeryAlso: NOTES, Natural orifice translumenal endoscopic surgery, Transrectal AppendectomyUsing endoscopic instruments a small incision will be made in the rectum wall and the endoscope will be advanced into the insufflated peritoneal cavity. At least one laparoscopic trocars will be placed through the abdominal wall for laparoscopic instrument insertion to manipulate and cut tissue. The flexible endoscope will provide visualization of the surgical field and flexible endoscopic instruments may be used to augment surgical manipulation with the laparoscopic instruments. The appendix will be removed through the anus. Endoscopic clips, sutures or tissue anchors (TAS)will be used to close the rectal access site. | Procedure or surgery | Transrectal NOTES appendectomy |
Primary outcome
operative time
Time frame: intraoperative
2 secondary outcomes
perioperative complications
Time frame: two weeks
closure strength
Time frame: intraoperative
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2015.
Related trials for Appendectomy, Laparoscopic
Not yet recruiting
Comparative Study Between Laparoscopic and Open Appendectomy of Complicated Appendicitis
Appendicitis, Perforated Appendicitis
Recruiting
Feasibility and Safety of a Pediatric ERAS Protocol for Laparoscopic Appendectomy
Appendectomy, Laparoscopic, Acute Appendicitis
Not yet recruitingPhase 3
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Appendicitis Perforated, Appendectomy, Laparoscopic
Active, not recruitingObservational study
Retrospective Acute Care Appendectomy Study
Acute Appendicitis
Not yet recruiting
Immediate Laparoscopic Appendectomy Versus Interval Laparoscopic Appendectomy for Early Appendicular Mass
Appendicular Mass, Acute Appendicitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anne-Marie Boller, M.D. principal investigator
Northwestern University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Endoscopically assisted Appendectomy Surgery in people with Appendectomy, Laparoscopic and Endoscopy, run by Northwestern University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Feb 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
operative time (time frame: intraoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2015.